Each year the "Strongers for Research" call awards individual mini-grants to under-40 young oncologists studying lung cancer. Here you find their stories, the research centre they work in, what they are working on now. Merit-based selection via independent Scientific Committee.
MD, Oncologist, PhD candidate in Translational Science
Azienda Ospedaliero-Universitaria di Parma
Immunotherapy DUAL-ITA study of how sex-related genetic and hormonal differences affect the efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC)....
4th-year resident in Medical Oncology
Azienda Ospedaliera Sant'Andrea, Roma
Supportive care Time ToxicityQuantifying the "time patients spend" on outpatient cancer care — visits, tests, treatments, waiting — as an under-recognised quality-of-life metric. Time toxicity is a dimension o...
Physician, Phase 1 Unit
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma
Biomarkers cfDNA-NSCLCIdentifying circulating biomarkers (cell-free DNA methylation + Integrated Stress Response transcripts) to predict response to immune checkpoint inhibitors in lung cancer. Goal: a...
Physician-researcher in Onco-Pulmonology
Azienda Ospedaliero-Universitaria Pisana — Pulmonary Unit
Immune-related toxicities IMPEREALA real-world analysis of the incidence of checkpoint inhibitor–induced pneumonitis (CIP) in lung cancer patients treated with immunotherapy. A 10-year retrospective cohort at AOU P...
Oncology researcher (scientific coordination by Prof. Armando Santoro)
Humanitas Research Hospital, Milano
AI / Imaging AI-ImagingDeveloping artificial intelligence models (GANs) to improve diagnostic imaging in lung cancer, focusing on early prediction and risk stratification. Project coordinated by Prof. Ar...
Under-40 oncology researcher
Università e centro di ricerca oncologica italiano
Trial access TrialBridgeAn initiative to reduce the gap in access to clinical trials for lung cancer patients — especially underrepresented populations (women, the elderly, patients with comorbidities). M...
Researcher at UNISA, Baronissi
Università degli Studi di Salerno — Dipartimento di Medicina, Chirurgia ed Odontoiatria
Biomarkers Immuno-SAFEDeveloping a non-invasive test based on salivary biomarkers (genetic, microbiome, immunological) to predict which lung cancer patients will develop immune-related adverse events (i...
The 2026 call will open in September. €3,000 mini-grants to under-40 oncologists working on lung cancer.
Discover the call Fund the next oneEvents, awarded grants, stories of the people who make research possible. One email a month, no spam.
